Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin-Assisted Therapy for Intergenerational Trauma
NCT06899165Phase 2Recruiting
- Start
- Aug 2026
- Primary completion
- May 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in major depressive disorder (MDD), anxiety disorder, psychological stress. Started Aug 2026; status: recruiting.
02
Drugs
psilocybin
03
Conditions
major depressive disorder (MDD)anxiety disorderpsychological stress
Beyond the preview
Go deeper on NCT06899165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06899165.